Concepedia

Salah A. Daghlas

SA

Statistics

Publications

4

Citations

94

H-Index

4

Active since

2016

Affiliations

University of Missouri(Current)

University of Missouri–Kansas City

Acceleron Pharma (United States)

University of Missouri Health System

Salah A. Daghlas is an author at University of Missouri specializing in medicine, osteogenesis, and signal transduction.

ORCID

Publications per year

2016–2021

4

Publications

4

Skeletal Response to Soluble Activin Receptor Type IIB in Mouse Models of Osteogenesis Imperfecta

Youngjae Jeong, Salah A. Daghlas, Yixia Xie et al. · Journal of Bone and Mineral Research · 2018 · 34 citations · Full text

, , +17

Soluble activin receptor type IIB decoy receptor differentially impacts murine osteogenesis imperfecta muscle function

Youngjae Jeong, Salah A. Daghlas, Alp S. Kahveci et al. · Muscle & Nerve · 2017 · 24 citations

, , +12

Relative effects of forced vital capacity and <scp>ALSFRS‐R</scp> on survival in <scp>ALS</scp>

Salah A. Daghlas, Raghav Govindarajan · Muscle & Nerve · 2021 · 21 citations

, , +16

Decreasing maternal myostatin programs adult offspring bone strength in a mouse model of osteogenesis imperfecta

Arin K. Oestreich, William M. Kamp, Marcus G. McCray et al. · Proceedings of the National Academy of Sciences · 2016 · 15 citations · Full text

, , +16

1–4 of 4